ATR-101 HCl
ATR-101 is a selective Acetyl CoA C-acetyltransferase inhibitor. ATR-101 is uniquely distributed to adrenal tissues and inhibition of adrenal ACAT1 by ATR-101 disrupts steroidogenesis and leads to selective apoptosis of steroid producing adrenocortical-derived cells. Phase-II clinical trials in Congenital adrenal hyperplasia in USA was on-going. In addiction, Phase I clinical trials in Adrenocortical carcinoma was on-going too.
| Supplier | BOC Sciences |
|---|---|
| Product # | 133825-81-7 |
| Pricing | Inquire |
| Cas | 133825-81-7 |
| Molecular Weight | 458.09 |
| Molecular Formula | C27H40ClN3O |
| Canonical SMILES | N(C(=O)NCC1(CCCC1)c1ccc(cc1)N(C)C)c1c(cccc1C(C)C)C(C)C.Cl |